Second-generation antibody protects from SARS-CoV-2, its variant and prevents it from mutating to resist therapy
The Institute for Research in Biomedicine (IRB; Bellinzona, Switzerland), affiliated with the Università della Svizzera italiana (USI) has developed a second-generation double antibody that protects against SARS-CoV-2, the ...